1.Prediction of early in-hospital major adverse events by D-dimer level in patients with acute type A aortic dissection: A retrospective cohort study
Yu WANG ; Xiaoqi WANG ; Heng ZHANG ; Xinyi ZHANG ; Mian XU ; Yi GUO ; Shuo CHANG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2025;32(11):1597-1602
Objective To investigate the association between D-dimer levels within 2 hours of admission and in-hospital major adverse events (MAEs) in patients with acute type A aortic dissection (ATAAD) who underwent total arch replacement combined with frozen elephant trunk (FET) implantation. Methods This retrospective study included patients with ATAAD who underwent total arch replacement with FET implantation at Fuwai Yunnan Cardiovascular Hospital from September 2017 to December 2022. Patients were divided into two groups based on the occurrence of in-hospital MAEs: a MAEs group and a non-MAEs group (control). Perioperative data were compared between the two groups. Univariate and multivariate logistic regression analyses were performed to identify risk factors for in-hospital MAEs, which included in-hospital death, gastrointestinal bleeding, paraplegia, acute kidney injury, low cardiac output syndrome, stroke, respiratory failure, multiple organ dysfunction syndrome, and severe infection. The predictive value of D-dimer was evaluated using the area under the receiver operating characteristic curve (AUC). Results A total of 218 patients were included (157 males, 61 females), with a mean age of (51.54±9.79) years. There were 152 patients in the non-MAEs group and 66 in the MAEs group. The overall incidence of in-hospital MAEs was 30.3%, and the in-hospital mortality rate was 2.8% (6/218). Compared to the non-MAEs group, the MAEs group had significantly higher levels of D-dimer and lactate, as well as longer cardiopulmonary bypass time, aortic cross-clamp time, and ICU length of stay (all P<0.05). Multivariate logistic regression analysis identified D-dimer as an independent risk factor for in-hospital MAEs [OR=1.077, 95%CI (1.020, 1.137), P=0.013]. The AUC for the D-dimer level within 2 hours of admission to predict in-hospital MAEs was 0.83 [95%CI (0.736, 0.870), P<0.001]. The optimal cutoff value was 2.2 μg/mL, with a sensitivity of 84.8% and a specificity of 73.0%. Conclusion The serum D-dimer level is an independent risk factor for in-hospital MAEs in patients with ATAAD following total arch replacement with FET implantation. D-dimer levels on admission can help clinicians optimize risk stratification and perioperative management, potentially reducing the incidence of early adverse events.
2.Intraspecific variation of Forsythia suspensa chloroplast genome.
Yu-Han LI ; Lin-Lin CAO ; Chang GUO ; Yi-Heng WANG ; Dan LIU ; Jia-Hui SUN ; Sheng WANG ; Gang-Min ZHANG ; Wen-Pan DONG
China Journal of Chinese Materia Medica 2025;50(8):2108-2115
Forsythia suspensa is a traditional Chinese medicine and a commonly used landscaping plant. Its dried fruit is used in medicine for its functions of clearing heat, removing toxins, reducing swelling, dissipating masses, and dispersing wind and heat. It possesses extremely high medicinal and economic value. However, the genetic differentiation and diversity of its wild populations remain unclear. In this study, chloroplast genome sequences were obtained from 15 wild individuals of F. suspensa using high-throughput sequencing technology. The sequence characteristics and intraspecific variations were analyzed. The results were as follows:(1) The full length of the F. suspensa chloroplast genome ranged from 156 184 to 156 479 bp, comprising a large single-copy region, a small single-copy region, and two inverted repeat regions. The chloroplast genome encoded a total of 132 genes, including 87 protein-coding genes, 37 tRNA genes, and 8 rRNA genes.(2) A total of 166-174 SSR loci, 792 SNV loci, and 63 InDel loci were identified in the F. suspensa chloroplast genome, indicating considerable genetic variation among individuals.(3) Population structure analysis revealed that F. suspensa could be divided into five or six groups. Both the population structure analysis and phylogenetic reconstruction results indicated significant genetic variation within the wild populations of F. suspensa, with no obvious correlation between intraspecific genetic differentiation and geographical distribution. This study provides new insights into the genetic diversity and differentiation within F. suspensa species and offers additional references for the conservation of species diversity and the utilization of germplasm resources in wild F. suspensa.
Genome, Chloroplast
;
Forsythia/classification*
;
Phylogeny
;
Genetic Variation
;
Chloroplasts/genetics*
;
Microsatellite Repeats
3.Analysis of volatile components in Yinhu Ganmao Powder by GC-MS/MS and content determination of nineteen constituents
Li-jun DENG ; Jin-feng LI ; Xi-ya GUO ; Xin-yi HU ; Zhi-heng SU ; Dan-feng LI
Chinese Traditional Patent Medicine 2025;47(11):3540-3548
AIM To establish a GC-MS/MS method for the analysis of volatile components in Yinhu Ganmao Powder,and to determine the contents of α-pinene,camphene,sabinene,β-pinene,α-terpinene,(+)-limonene,p-cymene,1,8-cineole,linalool,L-menthol,terpinen-4-ol,DL-menthol,α-terpineol,tridecane,pulegone,caryophyllene,humulene,n-hexadecane and patchouli alcohol.METHODS The analysis was performed on a DB-624 UI capillary column(30 m×0.25 mm×1.40 μm ),and electron ionization source was adopted with multiple reaction monitoring mode.RESULTS Fifty volatile components and twenty-five liposoluble components were identified in volatile oils and medicinal material powder,respectively.Nineteen constituents showed good linear relationships within their own ranges(r ≥ 0.999 0),whose average recoveries were 84.43%-113.31%with the RSDs of less than 9.15%.CONCLUSION This stable,accurate and reproducible method can provide a reference for the quality evaluation of Yinhu Ganmao Powder.
4.Analysis of China's cross-regional medical insurance settlement policy based on policy tools
Shi-qiang WANG ; Hui WANG ; Shu ZHANG ; Zi-qi ZHANG ; Yi-jie LI ; Jia-yi LIU ; Guo-heng HU
Chinese Journal of Health Policy 2025;18(10):32-39
Objective:Systematically review the release status and characteristics of policies related to cross-regional medical insurance settlement policies in China,providing reference for promoting the convenience of medical insurance settlement services and improving management efficiency.Methods:Using content analysis,a two-dimensional framework of"policy objectives-policy tools"was constructed.A total of 127 policy documents were coded and analyzed.Results:Demand-based tools were applied most frequently(43.6%),followed by environmental and supply-based tools.Policy objectives mainly focused on improving service convenience,supported by expanding coverage and ensuring regulatory security.Conclusions:China's cross-regional medical insurance settlement policies have improved service accessibility and strengthened institutional supervision while gradually expanding coverage.However,deficiencies remain in assessment refinement and emergency mechanisms.Greater interdepartmental coordination is needed to enhance regulatory linkage and ensure the safe operation of medical insurance funds.
5.Analysis of China's cross-regional medical insurance settlement policy based on policy tools
Shi-qiang WANG ; Hui WANG ; Shu ZHANG ; Zi-qi ZHANG ; Yi-jie LI ; Jia-yi LIU ; Guo-heng HU
Chinese Journal of Health Policy 2025;18(10):32-39
Objective:Systematically review the release status and characteristics of policies related to cross-regional medical insurance settlement policies in China,providing reference for promoting the convenience of medical insurance settlement services and improving management efficiency.Methods:Using content analysis,a two-dimensional framework of"policy objectives-policy tools"was constructed.A total of 127 policy documents were coded and analyzed.Results:Demand-based tools were applied most frequently(43.6%),followed by environmental and supply-based tools.Policy objectives mainly focused on improving service convenience,supported by expanding coverage and ensuring regulatory security.Conclusions:China's cross-regional medical insurance settlement policies have improved service accessibility and strengthened institutional supervision while gradually expanding coverage.However,deficiencies remain in assessment refinement and emergency mechanisms.Greater interdepartmental coordination is needed to enhance regulatory linkage and ensure the safe operation of medical insurance funds.
6.Analysis of volatile components in Yinhu Ganmao Powder by GC-MS/MS and content determination of nineteen constituents
Li-jun DENG ; Jin-feng LI ; Xi-ya GUO ; Xin-yi HU ; Zhi-heng SU ; Dan-feng LI
Chinese Traditional Patent Medicine 2025;47(11):3540-3548
AIM To establish a GC-MS/MS method for the analysis of volatile components in Yinhu Ganmao Powder,and to determine the contents of α-pinene,camphene,sabinene,β-pinene,α-terpinene,(+)-limonene,p-cymene,1,8-cineole,linalool,L-menthol,terpinen-4-ol,DL-menthol,α-terpineol,tridecane,pulegone,caryophyllene,humulene,n-hexadecane and patchouli alcohol.METHODS The analysis was performed on a DB-624 UI capillary column(30 m×0.25 mm×1.40 μm ),and electron ionization source was adopted with multiple reaction monitoring mode.RESULTS Fifty volatile components and twenty-five liposoluble components were identified in volatile oils and medicinal material powder,respectively.Nineteen constituents showed good linear relationships within their own ranges(r ≥ 0.999 0),whose average recoveries were 84.43%-113.31%with the RSDs of less than 9.15%.CONCLUSION This stable,accurate and reproducible method can provide a reference for the quality evaluation of Yinhu Ganmao Powder.
7.Protective effect of gastrodin combined with celecoxib on cartilage injury in rats with knee osteoarthritis through TLR4/NF-κB signaling pathway
Heng WANG ; Zhibin LI ; Xiaoxia GUO ; Chenxin YI ; Xiaoming ZHAO ; Zhi CHEN
International Journal of Biomedical Engineering 2024;47(6):560-567
Objective:To investigate the protective effect of gastrodin combined with celecoxib on cartilage injury in rats with knee osteoarthritis through Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling pathway.Methods:Knee osteoarthritis rat models were established by the modified Hulth method. According to the random number table method, rat models were randomly divided into the model group, the gastrodin group, the celecoxib group, and combined group with 10 rats in each group. An additional 10 healthy rats were selected and served as the control group. The rats in the gastrodin group received 50 mg/kg gastrodin by intraperitoneal injection. The rats in the celecoxib group received 4 mg/kg celecoxib by gavage. In the combined group, the rats received 50 mg/kg gastrodin by intraperitoneal injection, followed by 4 mg/kg celecoxib by gavage. Rats in both the control group and the model group received intraperitoneal injections and gavage of an equal volume of normal saline, which were administered once a day for 21 d. The symptoms of joint pain, the degree of joint swelling, the width of the knee joint, the joint function, and the cartilage thickness of the rats in all groups were compared. The expression level of proinflammatory factors, including interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-17 (IL-17), and tumor necrosis factor-α (TNF-α), in cartilage was determined by enzyme-linked immunosorbent assay (ELISA). The relative expression levels of TLR4 and NF-κB proteins and genes in cartilage were detected by Western blotting and real-time reverse transcription-PCR (RT-qPCR), respectively.Results:The mechanical pain threshold [(19.77±2.05) g] and thermal pain threshold [(10.06±1.54) s] in the combined group were higher than those in the model, gastrodin, and celecoxib groups [(5.27±1.23), (11.27±1.55), and (12.85±1.62) g for mechanical pain threshold, and (4.26±0.84), (7.21±1.31), (7.36±1.15) s for thermal pain threshold], respectively, and the differences were statistically significant (all P<0.05). The degree of joint swelling [(8.23±1.05)%], knee joint width [(5.19±0.23) mm], and gait score [(0.56±0.22) points] in the combined group were all lower than those in the model, gastrodin, and celecoxib groups [(38.26±6.77)%, (17.76±2.18)%, and (17.23±2.44)% for joint swelling degree, (9.86±1.16), (6.43±0.54), and (6.23±0.78) mm for knee joint width, and (2.25±0.47), (1.26±0.23), and (1.25±0.14) points for gait score], respectively, and the differences were statistically significant (all P<0.05). The levels of IL-1β [(53.37±10.26) pg/ml], IL-6 [(51.26±6.22) pg/ml], IL-17 [(136.33±8.67) pg/ml], and TNF-α [(62.36±12.03) pg/ml] in the cartilage tissue of rats in the combined group were all lower than those in the model, gastrodin, and celecoxib groups [IL-1β: (112.33±18.56), (76.55±12.03), (72.69±14.88) pg/ml; IL-6: (90.33±12.06), (69.23±8.09), (65.42±7.01) pg/ml; IL-17: (215.66±20.22), (165.33±14.69), (160.36±15.55) pg/ml; TNF-α: (138.09±18.26), (89.66±15.36), (84.03±14.77) pg/ml], respectively, and the differences were statistically significant (all P<0.05). Compared with the model group, the cartilage thickness of rats in the gastrodin, celecoxib, and combined groups [(945.86±63.87), (962.75±129.14), (1 410.48±60.42) μm] were increased, and the differences were statistically significant (all P<0.05). The relative expression levels of TLR4 and NF-κB proteins [(2.13±0.88), (2.01±0.35)] and mRNAs [(1.48±0.11), (1.73±0.12)] in the cartilage tissue of rats in the combined group were all lower than those in the model group [TLR4, NF-κB proteins: (5.26±0.95), (4.32±0.71); mRNAs: (4.37±0.43), (5.27±0.48)], the gastrodin group [TLR4, NF-κB proteins: (3.22±0.75), (3.16±0.33); mRNAs: (2.53±0.21), (3.52±0.22)], and the celecoxib group [TLR4, NF-κB proteins: (3.26±0.61), (3.19±0.30); mRNAs: (2.55±0.24), (3.55±0.31)], and the differences were statistically significant (all P<0.05). Conclusions:Gastrodin combined with celecoxib can inhibit the symptoms of joint pain and inflammation in rats with knee osteoarthritis by inhibiting the activation of TLR4/NF-κB signaling, and alleviate the cartilage injury.
8.Anatomical principal variations of the human pelvic ring using statistic shape model
Xiu-Yun SU ; Jie HE ; Wei ZHAO ; De-Shun SUN ; Heng LI ; Yi-Yi OU ; Guo-Xian PEI
Acta Anatomica Sinica 2024;55(6):715-720
Objective To construct a three-dimensional statistical shape model of the pelvis and analyze the individual variation and gender differences of the three-dimensional shape of the pelvis.Methods We collected CT data from 201 Chinese individuals and used deep learning to automatically reconstruct three-dimensional models of the pelvis.Through three-dimensional model registration,dense correspondence mesh mapping,and the use of statistical shape modelling(SSM)and principal component(PC)analysis method,we extracted models of variations(MoV)of pelvic shape changes and statistically compared the shape MoV between males and females.Results We analysed the top 10 principal components of shape variations,which accounted for 86.1%of the total variability.Among them,PC01,PC02,and PC04 showed significant differences between genders(P<0.001),accounting for a total variability of 60.1%.PC08 and PC 10 demonstrated pelvic asymmetry,accounting for a total variability of 3.8%.Conclusion We constructed a three-dimensional statistical shape model of the pelvis in Chinese individuals,revealing the morphological variation and sex differences of Chinese pelvis.
9.Genotype-environment interaction on arterial stiffness: A pedigree-based study.
Xue Heng WANG ; Si Yue WANG ; He Xiang PENG ; Meng FAN ; Huang Da GUO ; Tian Jiao HOU ; Meng Ying WANG ; Yi Qun WU ; Xue Ying QIN ; Xun TANG ; Jin LI ; Da Fang CHEN ; Yong Hua HU ; Tao WU
Journal of Peking University(Health Sciences) 2023;55(3):400-407
OBJECTIVE:
To utilized the baseline data of the Beijing Fangshan Family Cohort Study, and to estimate whether the association between a healthy lifestyle and arterial stiffness might be modified by genetic effects.
METHODS:
Probands and their relatives from 9 rural areas in Fangshan district, Beijing were included in this study. We developed a healthy lifestyle score based on five lifestyle behaviors: smoking, alcohol consumption, body mass index (BMI), dietary pattern, and physical activity. The measurements of arterial stiffness were brachial-ankle pulse wave velocity (baPWV) and ankle-brachial index (ABI). A variance component model was used to determine the heritability of arterial stiffness. Genotype-environment interaction effects were performed by the maximum likelihood methods. Subsequently, 45 candidate single nucleotide polymorphisms (SNPs) located in the glycolipid metabolism pathway were selected, and generalized estimated equations were used to assess the gene-environment interaction effects between particular genetic loci and healthy lifestyles.
RESULTS:
A total of 6 302 study subjects across 3 225 pedigrees were enrolled in this study, with a mean age of 56.9 years and 45.1% male. Heritability of baPWV and ABI was 0.360 (95%CI: 0.302-0.418) and 0.243 (95%CI: 0.175-0.311), respectively. Significant genotype-healthy diet interaction on baPWV and genotype-BMI interaction on ABI were observed. Following the findings of genotype-environment interaction analysis, we further identified two SNPs located in ADAMTS9-AS2 and CDH13 might modify the association between healthy dietary pattern and arterial stiffness, indicating that adherence to a healthy dietary pattern might attenuate the genetic risk on arterial stiffness. Three SNPs in CDKAL1, ATP8B2 and SLC30A8 were shown to interact with BMI, implying that maintaining BMI within a healthy range might decrease the genetic risk of arterial stiffness.
CONCLUSION
The current study discovered that genotype-healthy dietary pattern and genotype-BMI interactions might affect the risk of arterial stiffness. Furthermore, we identified five genetic loci that might modify the relationship between healthy dietary pattern and BMI with arterial stiffness. Our findings suggested that a healthy lifestyle may reduce the genetic risk of arterial stiffness. This study has laid the groundwork for future research exploring mechanisms of arterial stiffness.
Humans
;
Male
;
Middle Aged
;
Female
;
Ankle Brachial Index
;
Cohort Studies
;
Gene-Environment Interaction
;
Vascular Stiffness/genetics*
;
Pedigree
;
Pulse Wave Analysis/methods*
;
Genotype
10.Pathological features and immune microenvironment in HER-2 intratumoral heterogeneous breast cancers.
Yi Ling YANG ; Yuan Ming SONG ; Hui Qin XUE ; Hui SUN ; Ya Qing LI ; Xiao Long QIAN ; Jiao JIAO ; Kun Peng LI ; Heng ZHANG ; Xiao Jing GUO
Chinese Journal of Oncology 2023;45(2):165-169
Objective: To observe the clinical pathology features, and immune microenvironment of HER-2 intratumoral heterogeneity breast cancer. Methods: Thirty cases of HER-2 intratumoral heterogeneous breast cancer were retrospectively analyzed in Tianjin Medical University Cancer Institute and Hospital from November 2017 to June 2020. HER-2 expression was detected by immunohistochemistry and verified by dual color silver-enhanced in-situ hybridization (D-SISH). HER-2 intratumoral positive and negative regions were divided. The pathological characteristics, subtype, and the level of tumor infiltrating lymphocytes (TILs) and the expression of programmed cell death-ligand 1 (PD-L1) were evaluated respectively. Results: The proportion of HER-2 positive cells of the breast cancer ranged from 10% to 90%. The pathological type was mainly invasive non-special typecarcinoma. Six cases presented different pathological types between HER-2 positive and negative regions. The HER-2-positive areas included 2 cases of carcinoma with apocrine differentiation, and the negative areas included 2 cases of invasive micropapillary carcinoma, 1 case of invasive papillary carcinoma, and 1 case of carcinoma with apocrine differentiation. In HER-2 positive regions, 17 cases were Luminal B and 13 cases were HER-2 overexpressed types. There were 22 cases of Luminal B and 8 cases of triple negative tumors in the HER-2 negative areas. The levels of TILs in HER-2 positive and negative areas accounted for 53.3% (16/30) and 26.7% (8/30), respectively, with a statistically significant difference (P=0.035). The positive expression of PD-L1 in HER-2 positive area and HER-2 negative area were 6 cases and 9 cases, respectively. Among 8 cases with HER-2 negative regions containing triple negative components, 4 cases were positive for PD-L1 expression. Conclusions: In the case of HER-2 intratumoral heterogeneity, it is necessary to pay attention to both HER-2 positive and negative regions, and evaluate subtype separately as far as possible. For HER-2 intratumoral heterogeneous breast cancer containing triple negative components, the treatment mode can be optimized by refining the intratumoral expression of PD-L1.
Humans
;
Female
;
Breast Neoplasms/pathology*
;
Retrospective Studies
;
B7-H1 Antigen/metabolism*
;
Lymphocytes, Tumor-Infiltrating/pathology*
;
Carcinoma
;
Tumor Microenvironment
;
Triple Negative Breast Neoplasms/pathology*
;
Prognosis
;
Biomarkers, Tumor/metabolism*

Result Analysis
Print
Save
E-mail